Dear collegues,
We are interested in opinions about the choice of analytes for
neuroblastoma screening.
Should it be NE/E, MN/NMN or the usual VMA/HVA in urine?
Literature seems relatively scarce, especially with large patient
groups, as is the frequency of occurrence.
Best regards,
Raymond Wulkan
Zuiderziekenhuis
Rotterdam-NL
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
|